Agrify and Front Range Biosciences Announce Partnership to Develop Next Generation Cultivation and Genetics Solution

Research and development partnership will combine Agrify’s cutting-edge indoor agriculture cultivation solutions with Front Range Biosciences’ expertise in creating unique cannabis and hemp cultivars


MASSACHUSETTS:  Agrify Corporation, a developer of highly advanced and proprietary precision hardware and software cultivation solutions for the indoor agriculture marketplace, and Front Range Biosciences®, a cannabis and hemp genetics platform company that leverages next generation breeding technology and research and development capabilities, today announced a signed definitive agreement to push the boundaries of cannabis and hemp genetics via the application and incorporation of technology to the genetic and cultivation processes.

The R&D partnership will be based in California and Colorado, including the installation of Agrify Vertical Farming Units at FRB’s indoor breeding facilities. The primary focus of the program will be optimizing cannabis and hemp cultivation environments to drive the best performance from different genetic cultivars to achieve maximum yield, consistency, and terpene output with minimum variance in cannabinoid levels. The program will focus on unlocking the cannabis derived product potential in both adult use and medical markets by optimizing terpene and cannabinoid combinations.

“Combining our expertise in developing optimized controlled cultivation environments through our proprietary hardware and software technology solutions with FRB’s ability to create second-to-none unique cannabis and hemp strains has the potential to transform the market,” said Raymond Chang, Chief Executive Officer of Agrify. “This partnership will bring together Agrify’s granularly controlled cultivation environments and next-level data analytics with FRB’s intentionally created genetics and cutting-edge breeding expertise to form what we believe will be the foundation of the next generation of consumer products with higher levels of consistency and increased concentrations of valuable phytochemicals. We are thrilled to be collaborating with FRB on this initiative and commencing this exciting work together.”

“We believe our strategic partnership with Agrify will leverage our innovative breeding platform and broad product pipeline of cannabis cultivars with Agrify’s leading cultivation solutions to create an offering that will enable cultivators to deliver on growing consumer demands for unique and appealing new products and experiences,” said Dr. Jonathan Vaught, Chief Executive Officer and Co-Founder of Front Range Biosciences. “Our emphasis on terpene content and minor cannabinoids will drive new and exciting flavors and experiences as the cannabis market evolves beyond measuring value simply by the THC content. In addition to enabling consumer product differentiation through genetics, we are also excited to leverage the combination of the two platforms to optimize production and deliver yield improvements for large scale cultivation, enabling more efficient scaling of the industry as legalization continues to open up new markets.”

Front Range Biosciences Partners With University of California, Davis For Cannabis Genomics Research

Agricultural biotech company collaborates with world’s leading agriculture school for research

CALIFORNIA: Front Range Biosciences, a leading agricultural biotech company, has launched a genomics research initiative with the University of California, Davis, to advance understanding of cannabis for medical and nutraceutical uses.  The research team consists of Professor Dario Cantu in the Department of Viticulture and Enology, research scientists in the Cantu lab, and members of the FRB team.

“We have successfully applied cutting-edge DNA sequencing technologies and computational approaches to study challenging genomes of diverse crops and associated microorganisms. We are now excited to have the opportunity to study the genome of hemp. Decoding its genome will allow us to gain new insight into the genetic bases of complex pathways of secondary metabolism in plants,” said Dr. Cantu.

“UC Davis is renowned as the leading agriculture university in the world and we are excited to work with Dr. Cantu’s team to improve this crop to reduce pesticide residues and excessive application of fertilizers, in preparation for production targeting medically beneficial compounds,” said Dr. Jonathan Vaught, CEO of FRB.

During the project, FRB will isolate DNA from hemp cultivars that are low in THC and solely for industrial uses. The company will send these DNA samples to UC Davis for Next-Generation Sequencing and bioinformatic analysis to create a better genome reference for cannabis.

To fund the project, FRB pledged a gift, to be fulfilled over a one-year period, to The Regents of University of California to support UC Davis’ development and annotation of the cannabis genome. FRB gift will cover costs related to supplies, DNA and RNA sequencing, assembly and annotation of the cannabis genome.